Comprehensive pharmacogenomics profiling of the Serbian population
In conclusion, significant differences in frequencies of pharmacogenetic phenotypes that influence response to several drug categories including statins and antidepressants indicate that inclusion of data relevant for drug response to genetic reports would be beneficial in the Serbian population. Implementation of pharmacogenetic testing could be achieved through analysis of clinical and whole exome sequencing data.
Authors
- Biljana Stanković (ORCID: https://orcid.org/0000-0002-7571-277X)
- Bojan Ristivojević (ORCID: https://orcid.org/0000-0003-0600-7345)
- Sonja Pavlović (ORCID: https://orcid.org/0000-0002-2915-1641)
- Djordje Pavlovic (ORCID: https://orcid.org/0000-0001-9379-867X)
- Branka Zukić (ORCID: https://orcid.org/0000-0002-3518-6330)
- Nikola Kotur
- Marina Jelovac (ORCID: https://orcid.org/0000-0003-1344-7867)
Institutions
- University of Belgrade (RS)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.3389/fphar.2025.1553536
- Citations
- 1
- Primary Topic
- Nutrition, Genetics, and Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- European Commission